Non Active Secondary Progressive Multiple Sclerosis clinical trials

Explore recruiting non active secondary progressive multiple sclerosis clinical trials.

Recruiting non active secondary progressive multiple sclerosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Active Secondary Progressive Multiple Sclerosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Germany, Bulgaria, Netherlands, Sweden, Portugal, Croatia +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a Study of SUN-627 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Impact on Measures of Neuroinflammation in the Central Nervous System in Participants With Non-Active Progressive Multiple Sclerosis (SPMS/PPMS)

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Active Secondary Progressive Multiple Sclerosis trials by city

Non Active Secondary Progressive Multiple Sclerosis in Toronto Non Active Secondary Progressive Multiple Sclerosis in Vancouver Non Active Secondary Progressive Multiple Sclerosis in Montreal Non Active Secondary Progressive Multiple Sclerosis in Calgary Non Active Secondary Progressive Multiple Sclerosis in Edmonton Non Active Secondary Progressive Multiple Sclerosis in Ottawa Non Active Secondary Progressive Multiple Sclerosis in Winnipeg Non Active Secondary Progressive Multiple Sclerosis in Quebec City Non Active Secondary Progressive Multiple Sclerosis in Hamilton Non Active Secondary Progressive Multiple Sclerosis in Kitchener Non Active Secondary Progressive Multiple Sclerosis in London Non Active Secondary Progressive Multiple Sclerosis in Halifax Non Active Secondary Progressive Multiple Sclerosis in New York Non Active Secondary Progressive Multiple Sclerosis in Los Angeles Non Active Secondary Progressive Multiple Sclerosis in Chicago Non Active Secondary Progressive Multiple Sclerosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease